Market Overview:
The Global Market for Home Testing Kits Estimated at USD 3.6 Billion In the Year 2022, Is Projected To Reach A Revised Size Of USD 5.9 Billion By 2030, Growing At A CAGR Of 6.31 % Over The Forecast Period 2022-2030.
Home testing kits are convenient and rapid instruments that enable individuals to perform various health tests at home and obtain results within minutes. They serve as advanced versions of point-of-care test kits used by healthcare professionals and are designed for wellness, prevention, and managing acute and chronic conditions. The market offers a wide range of home test kits, including HIV, pregnancy, diabetes, ovulation, and infectious disease tests like malaria and COVID-19. The increasing popularity of self-help and do-it-yourself (DIY) test kits is attributed to their ease of use and quick results, driving the growth of the home test kit market.
Top Key Players for the Home Testing Kits Market:
Abbott(US), ACON Laboratories Inc. (US), Rapikit (US), BTNX INC. (Canada), bioLytical Laboratories Inc. (Canada), OraSure Technologies Inc. (USA), BD (US), Cardinal Health (USA),B. Braun Melsungen AG (Germany), Piramal Enterprises Ltd. (India), PRIMA Lab SA (Switzerland), Siemens Healthcare GmbH (Germany), Quidel Corporation (California), Bionime Corporation (California), SA Scientific (US), ARKRAY USA Inc. (USA), Everlywell Inc. (US), Nova Biomedical (Waltham, MA), Eurofins Viracor Inc. (US), SelfDiagnostics OU (Estonia), AdvaCare Pharma (Shanghai), AccuBio Tech Co. Ltd (China), BioSure (UK), Atlas Medical (UK), TaiDoc Technology Corporation (Taiwan), LifeScan IP Holdings LLC (Switzerland), Chembio Diagnostics Inc. (US), Drägerwerk AG & Co. KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and other major players.
Market Dynamics and Factors for Home Testing Kits Market:
Drivers:
Rising Adoption of The Home Testing Kits
Increasing awareness among the population regarding new products, particularly home testing kits, is a key driver of market growth. The rising prevalence of chronic diseases like heart disease and diabetes has further fueled this demand. With growing awareness about disease prevention, many individuals prefer the convenience of home test kits for regular check-ups, especially considering the challenges posed by daily hospital visits. The COVID-19 pandemic has also significantly increased the demand for these kits due to restrictions and the ease of availability both online and offline at pharmacies. As a result, the home testing kit market is expected to continue its growth trajectory in the forecast period.
Opportunities:
Opportunity in the Advanced Technologies
The home testing kit market is presented with lucrative opportunities through the adoption of cutting-edge technologies in medical products. Artificial Intelligence (AI) and Machine Learning play pivotal roles in healthcare, enhancing patient safety and automating processes. With the growing prevalence of infectious diseases, manufacturers and governments are investing more in new products. For example, DAM Health introduced a home test kit in March 2022, utilizing AI technology for rapid and precise results. Embracing these novel advanced technologies offers significant growth prospects for the home testing kits market in the forecast period.
Segmentation Analysis of the Home Testing Kits Market:
By Test Type, the glucose test is expected to have the maximum share in the home testing kit market during the forecast periods. Owing to the growing prevalence of diabetes patients around the world.
By Distribution Channels, online pharmacies are dominated the market share of home test kits. Owing to the growing prevalence of various infectious diseases, rising the trend of purchasing medicines online.
Regional Analysis of the Home Testing Kits Market:
North America is poised to lead the home testing kit market due to its high healthcare expenditure and increasing awareness of the benefits of these kits. The region faces a significant prevalence of diseases like diabetes, heart disease, and infectious diseases, including COVID-19. Moreover, the availability of various home testing kits, particularly pregnancy tests, contributes to the market's growth. In the Asia Pacific (APAC), the second dominant region, the large population base and high prevalence of infectious diseases, including diabetes, drive the demand for home testing kits.
Key Industry Development:
In July 2021, Abbott, a medical device company launched covid-19 home test kits in India for the detection of symptomatic or asymptomatic SARS-COV-2 virus. Panbio Covid-19 is the name of this new kit.
In November 2020, the US Food and Drug Administration authorized the first covid-19 test kit for self-testing at home. The name of the kit is Lucira COVID-19 All-In-One Test Kit test is a molecular single-use test that detects the coronavirus.
Regional Outlook (Revenue in USD Million; Volume in Units, 2023-2030)
North America
- The U.S.
- Canada
- Mexico
Eastern Europe
- Russia
- Bulgaria
- The Czech Republic
- Hungary
- Poland
- Romania
- Rest of Eastern Europe
Western Europe
- Germany
- UK
- France
- Netherlands
- Italy
- Spain
- Rest of Western Europe
Asia Pacific
- China
- India
- Japan
- Singapore
- Australia
- New-Zealand
- Rest of APAC
Middle East & Africa
- Turkey
- Saudi Arabia
- Qatar
- UAE
- Israel
- South Africa
South America
- Brazil
- Argentina
- Rest of SA
